DAFTAR PUSTAKA

1. Anonymous. World Health Organization (WHO). Global summary of the

AIDS
epidemic
2014.
(online),
(http://www.who.int/hiv/data/epi_core_july2015.png?ua=1, diakses 4 Maret
2016).
2. Pusat Data dan Informasi Kementerian Kesehatan RI. Situasi dan analisis
HIV AIDS. Jakarta: Infodatin; 2014.
3. Ditjen PP & PL Kemenkes RI. Statistik kasus HIV/AIDS di Indonesia
dilapor sampai dengan September 2014. Jakarta: Kemenkes RI; 2014.
4. Houshang R, Leila E, Mohammad RHM, Rosita V, Mehdi N, Mohammad
RS, et al. Evaluation of non-viral surrogate markers as predictive indicators
for monitoring progression of Human Immunodeficiency Virus Infection :
an eight-year analysis in a regional cente. Japanese Journal of Infectious
Diseases. 2016;69:39.
5. Suastika NKW. Akurasi diagnostik kombinasi Total Lymphocyte Count dan
kadar hemoglobin untuk memprediksi imunodefisiensi berat pada penderita
terinfeksi Human Immunodeficiency Virus (HIV) pra terapi antiretroviral.
Denpasar: Universitas Udayana; 2013.
6. Marrigje A de Jong, Rudi W, Hinta M, Agnes I, Andre JAM de Ven, Bachti
A, et al. Total lymphocyte count is reliable surrogate marker for CD4 cell
counts after the first year of antiretroviral therapy: data from an Indonesian
cohort study. Tropical Medicine and International Health. 2012;17:581.
7. Swity AF, Setiabudi D, Garna H. Korelasi Total Lymphocyte Count terhadap
CD4 pada anak dengan infeksi Human Immunodeficiency Virus. Sari
Pediatri. 2013;15:81-6.
8. World Health Organization. Laboratory guidelines for enumerating CD4 T
lymphocytes in the context of HIV/AIDS. New Delhi: WHO; 2007.
9. Ardo S, Christine S, Ronald J. Korelasi antara Total Lymphocyte Count dan
CD4 count pada pasien HIV/AIDS. Bandung: FK Universitas Kristen
Maranatha; 2013.
10. Jean-Philippe J, Albert C, Devin S, Robyn LS, Dmitry L, Marc CD, et al.
Crystal structure of a soluble cleaved HIV-1 envelope trimer. National
Institutes of Health. 2013;342:1.
11. Levinson W. Review of medical microbiology and immunology. Edisi 13.
United States: McGraw-Hill Education; 2014.
40
Universitas Lambung Mangkurat

41

12. Brooks GF, Carroll KC, Butel JS, Morse SA, Mietzner TA. Jawetz, Melnick,
& Adelbergs medical microbiology. Edisi 16. United States: McGraw-Hill
Companies; 2013.
13. Dmitry L, Jean-Philippe J, Natalia de Val, Albert C, Clinton SP, Per JK.
Cryo-EM structure of a fully glycosylated soluble cleaved HIV-1 Env
trimer. National Institutes of Health. 2013;342:1484.
14. Price SA, Wilson LM. Patofisiologi konsep klinis proses-proses penyakit.
Jakarta: EGC; 2006.
15. Linda A, Sawitri, Yunia ES, Desy HP. Viral load pada infeksi HIV. Berkala
Ilmu Kesehatan Kulit & Kelamin. 2009;21:32-3.
16. Badrul M, Didi C. Manifestasi HIV AIDS pada kasus neurologi : studi
epidemiologi di Rumah Sakit Saiful Anwar Malang tahun 2013-2014. MNJ.
2015;01:8.
17. Marie H, Gitte K, Carsten SL, Gitte P, Court P, Niels O, et al. CD4 decline
is associated with increased risk of cardiovascular disease, cancer, and death
in virally suppressed patients with HIV. CID. 2013;57:314.
18. Alberta VH. Hubungan antara hitung sel CD4 dengan kejadian retinitis pada
pasien HIV di RSUP dr. Kariadi Semarang. Semarang: UNDIP; 2012.
19. Matthieu P, Anne-Laure S, Elisa DC, Jean-Marc C, Rafael C, Elias KH, et
al. Follicular helper T cells serve as the major CD4 T cell compartment for
HIV-1 infection, replication, and production. The Journal of Experimental
Medicine. 2013;210:143.
20. World Health Organization. WHO case definitions of HIV for surveillance
and revised clinical staging and immunological classification of HIV-related
disease in adults and children. Geneva: WHO; 2007.
21. Eileen S, Suzanne W, M Kathleen G, Kenneth D, Andrew M, Matthew TM.
Revised surveillance case definitions for HIV infection among adults,
adolescents, and children aged <18 months and for HIV infection and AIDS
among children aged 18 months to <13 years. CDC. 2008;57:1-8.
22. Himanshu G, Jonathan M, Anjali J. HIV-1 induced bystander apoptosis.
Viruses. 2012;4:3020.
23. Hartawan J. Hubungan jumlah limfosit total dan limfosit T CD4+ dengan
gangguan fungsi kognitif pada pasien HIV-AIDS. Semarang: Universitas
Diponegoro; 2011.

Universitas Lambung Mangkurat

42

24. Guyton AC, Hall JE. Buku ajar fisiologi kedokteran. Edisi 11. Jakarta: EGC;
2007.
25. Sreenivasan S, Dasegowda V. Total lymphocyte count as a tool for timing
opportunistic infection prophylaxis in resource-limited settings: a study
from India. J Infect Dev Ctries. 2010;4(10):645-9.
26. Deresse D, Eskindir L. Relationship between Total Lymphocye Count
(TLC) and CD4 count among peoples living with HIV, Southern Etiopia: a
retrospective evaluation. AIDS Research and Theraphy. 2008;5:26.
27. Madiyono B, Moeslichan S, Sastroasmoro S, Budiman I, Purwanto SH.
Dasar-dasar metodologi peneletian klinis. Edisi 4. Jakarta: Sagung Seto;
2011.
28. Andrew R, David P, Keith AC, Edward CH. The causes and consequences
of HIV evolution. Nature Reviews Genetics. 2004;5:52.
29. International Association of Providers of AIDS Care, New Mexico AIDS

Education and Training Center. AIDS InfoNet. HIV life cycle. (online),
(http://www.aidsinfonet.org/uploaded/factsheets/8_eng_106.
pdf, diakses 31 Agustus 2016).

Universitas Lambung Mangkurat